Recombinant Protein Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4114961
- 96 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Recombinant Protein Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Recombinant Protein Drugs market segmented into
Recombinant DNA
Recombinant RNA
Based on the end-use, the global Recombinant Protein Drugs market classified into
Pharmaceutical Industry
Others
Based on geography, the global Recombinant Protein Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RECOMBINANT PROTEIN DRUGS INDUSTRY
2.1 Summary about Recombinant Protein Drugs Industry
2.2 Recombinant Protein Drugs Market Trends
2.2.1 Recombinant Protein Drugs Production & Consumption Trends
2.2.2 Recombinant Protein Drugs Demand Structure Trends
2.3 Recombinant Protein Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Recombinant DNA
4.2.2 Recombinant RNA
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pharmaceutical Industry
4.3.2 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Recombinant DNA
5.2.2 Recombinant RNA
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pharmaceutical Industry
5.3.2 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Recombinant DNA
6.2.2 Recombinant RNA
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pharmaceutical Industry
6.3.2 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Recombinant DNA
7.2.2 Recombinant RNA
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pharmaceutical Industry
7.3.2 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Recombinant DNA
8.2.2 Recombinant RNA
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pharmaceutical Industry
8.3.2 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Recombinant DNA
9.2.2 Recombinant RNA
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pharmaceutical Industry
9.3.2 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novo Nordisk
10.1.2 Amgen
10.1.3 Sanofi
10.1.4 Eli Lilly
10.1.5 Merck Serono
10.1.6 Ortho Biotech
10.1.7 Roche
10.1.8 Kyowa Hakko Kirin
10.1.9 Pharmingen
10.1.10 Abcam
10.1.11 GenSci
10.1.12 SL PHARM
10.1.13 Dongbao Pharm
10.1.14 Ankebio
10.1.15 NCPC
10.1.16 Heng Rui
10.2 Recombinant Protein Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Novo Nordisk
10.2.2 Amgen
10.2.3 Sanofi
10.2.4 Eli Lilly
10.2.5 Merck Serono
10.2.6 Ortho Biotech
10.2.7 Roche
10.2.8 Kyowa Hakko Kirin
10.2.9 Pharmingen
10.2.10 Abcam
10.2.11 GenSci
10.2.12 SL PHARM
10.2.13 Dongbao Pharm
10.2.14 Ankebio
10.2.15 NCPC
10.2.16 Heng Rui
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Recombinant Protein Drugs Product Type Overview
2.Table Recombinant Protein Drugs Product Type Market Share List
3.Table Recombinant Protein Drugs Product Type of Major Players
4.Table Brief Introduction of Novo Nordisk
5.Table Brief Introduction of Amgen
6.Table Brief Introduction of Sanofi
7.Table Brief Introduction of Eli Lilly
8.Table Brief Introduction of Merck Serono
9.Table Brief Introduction of Ortho Biotech
10.Table Brief Introduction of Roche
11.Table Brief Introduction of Kyowa Hakko Kirin
12.Table Brief Introduction of Pharmingen
13.Table Brief Introduction of Abcam
14.Table Brief Introduction of GenSci
15.Table Brief Introduction of SL PHARM
16.Table Brief Introduction of Dongbao Pharm
17.Table Brief Introduction of Ankebio
18.Table Brief Introduction of NCPC
19.Table Brief Introduction of Heng Rui
20.Table Products & Services of Novo Nordisk
21.Table Products & Services of Amgen
22.Table Products & Services of Sanofi
23.Table Products & Services of Eli Lilly
24.Table Products & Services of Merck Serono
25.Table Products & Services of Ortho Biotech
26.Table Products & Services of Roche
27.Table Products & Services of Kyowa Hakko Kirin
28.Table Products & Services of Pharmingen
29.Table Products & Services of Abcam
30.Table Products & Services of GenSci
31.Table Products & Services of SL PHARM
32.Table Products & Services of Dongbao Pharm
33.Table Products & Services of Ankebio
34.Table Products & Services of NCPC
35.Table Products & Services of Heng Rui
36.Table Market Distribution of Major Players
37.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
38.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
39.Table Global Recombinant Protein Drugs Market Forecast (Million USD) by Region 2021f-2026f
40.Table Global Recombinant Protein Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
41.Table Global Recombinant Protein Drugs Market Forecast (Million USD) by Demand 2021f-2026f
42.Table Global Recombinant Protein Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
